Nf1+/− mast cells induce neurofibroma like phenotypes through secreted TGF-β signaling
Open Access
- 11 July 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Molecular Genetics
- Vol. 15 (16) , 2421-2437
- https://doi.org/10.1093/hmg/ddl165
Abstract
Neurofibromas are common tumors found in neurofibromatosis type 1 (NF1) patients. These complex tumors are composed of Schwann cells, mast cells, fibroblasts and perineurial cells embedded in collagen that provide a lattice for tumor invasion. Genetic studies demonstrate that in neurofibromas, nullizygous loss of Nf1 in Schwann cells and haploinsufficiency of Nf1 in non-neuronal cells are required for tumorigenesis. Fibroblasts are a major cellular constituent in neurofibromas and are a source of collagen that constitutes ∼50% of the dry weight of the tumor. Here, we show that two of the prevalent heterozygous cells found in neurofibromas, mast cells and fibroblasts interact directly to contribute to tumor phenotype. Nf1+/− mast cells secrete elevated concentrations of the profibrotic transforming growth factor-beta (TGF-β). In response to TGF-β, both murine Nf1+/− fibroblasts and fibroblasts from human neurofibromas proliferate and synthesize excessive collagen, a hallmark of neurofibromas. We also establish that the TGF-β response occurs via hyperactivation of a novel Ras-c-abl signaling pathway. Genetic or pharmacological inhibition of c-abl reverses fibroblast proliferation and collagen synthesis to wild-type levels.These studies identify a novel molecular target to inhibit neurofibroma formation.Keywords
This publication has 47 references indexed in Scilit:
- Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-β: implications for carcinogenesisOncogene, 2005
- Stromal fibroblasts in cancer initiation and progressionNature, 2004
- Disruption of Basal JNK Activity Differentially Affects Key Fibroblast Functions Important for Wound HealingJournal of Biological Chemistry, 2003
- Targeting RAS signalling pathways in cancer therapyNature Reviews Cancer, 2003
- Inflammation and cancerNature, 2002
- Rhodocetin antagonizes stromal tumor invasion in vitro and other α2β1 integrin-mediated cell functionsMatrix Biology, 2002
- Neurofibromin GTPase-activating Protein-related Domains Restore Normal Growth in Nf1−/− CellsJournal of Biological Chemistry, 2001
- Mast cells enhance contraction of three‐dimensional collagen lattices by fibroblasts by cell–cell interaction: role of stem cell factor/c‐kitImmunology, 2000
- Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formationThe EMBO Journal, 1998
- Identification of NF1 mutations in both alleles of a dermal neurofibromaNature Genetics, 1996